Brief: Suven Life Sciences Secures Product Patents In Canada, India
Dec 21 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* SAYS SECURES PRODUCT PATENTS IN CANADA AND INDIA
* SAYS PATENT CORRESPONDING TO NEW CHEMICAL ENTITIES (NCES)
FOR
TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE
DISEASES
* SAYS CANADA AND INDIA PATENTS ARE VALID THROUGH 2034 AND
2028
RESPECTIVELY
Source text: http://bit.ly/2p0HvRY
Further company coverage: SUVP.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees